# Ruconest

NDC: 71274-350
Generic name: c1 esterase inhibitor recombinant
Labeler / Manufacturer: Pharming Healthcare Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180401

FDA application: BLA125495

## Active ingredients

- CONESTAT ALFA: 2100 U/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71274-350"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71274-350
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=66d3fecb-32a4-7781-e053-2a91aa0a83ca